Gene: TEDC2
Official Full Name: tubulin epsilon and delta complex 2provided by HGNC
Gene Summary: Predicted to be involved in positive regulation of smoothened signaling pathway. Predicted to be located in centriole and cilium. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02532 | TEDC2 Knockout cell line (HeLa) | Human | TEDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO02533 | TEDC2 Knockout cell line (HCT 116) | Human | TEDC2 | 1:2~1:4 | Negative | Online Inquiry |
KO02534 | TEDC2 Knockout cell line (HEK293) | Human | TEDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO02535 | TEDC2 Knockout cell line (A549) | Human | TEDC2 | 1:3~1:4 | Negative | Online Inquiry |
TEDC2 Gene Knockout Cell Lines are specialized cellular models designed for the targeted disruption of the TEDC2 gene, which is implicated in various biological processes and disease states. The creation of knockout cell lines involves the use of advanced genome-editing techniques, such as CRISPR/Cas9 or RNA interference, to precisely eliminate the function of the TEDC2 gene. This allows researchers to investigate the gene's role in cellular mechanisms, signaling pathways, and its potential contributions to pathologies.
The primary function of the TEDC2 Gene Knockout Cell Lines is to provide a platform for understanding the biological consequences of loss of TEDC2 expression in diverse contexts. By examining these knockout models, scientists can unravel the implications of TEDC2's absence, including its effects on cell proliferation, differentiation, and response to stressors. These cell lines also enable researchers to assess the therapeutic potential of targeting TEDC2 in disease models, contributing to the development of innovative treatments.
In both research and clinical settings, TEDC2 knockout cell lines are invaluable for pharmacological screening, gene function studies, and biomarker discovery. They serve as a critical resource for elucidating the role of TEDC2 in diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. Furthermore, these cell lines can facilitate the identification of novel drug targets and help in validating therapeutic strategies aimed at modulating TEDC2 activity.
Compared to alternative models, TEDC2 Gene Knockout Cell Lines offer enhanced specificity and reliability in studying gene function, as they allow for the complete ablation of the gene, eliminating compensatory mechanisms that may occur in non-knockout systems. Researchers can achieve greater confidence in their findings and accelerate the pace of their investigations with these models.
The value of TEDC2 Gene Knockout Cell Lines lies not only in their ability to advance our understanding of gene function but also in their potential to pave the way for novel clinical applications. With a commitment to scientific excellence and innovation, our company specializes in delivering high-quality biological products, including a range of knockout cell lines tailored to meet the diverse needs of researchers and clinicians in their quest for breakthrough discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.